FREE SHIPPING with every SuperJeweler.com order! Shop Now
Published On: Thu, Sep 12th, 2019

Tocagen’s brain cancer treatment fails late-stage study, shares slump

Tocagen Inc said on Thursday its experimental treatment did not prove effective in extending life of brain cancer patients in a late-stage study, sending shares down 68%.


Reuters: Health News

FREE SHIPPING with every SuperJeweler.com order! Shop Now

About the Author

-

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Advertisements

Powered by WP Robot

Tocagen’s brain cancer treatment fails late-stage study, shares slump